CC BY-NC-ND 4.0 · Journal of Fetal Medicine 2020; 07(01): 31-35
DOI: 10.1007/s40556-019-00227-5
Review Article

Toxoplasmosis in Pregnancy

1   Resolution Fetal Medicine Centre, Navodaya Hospitals, Secunderabad, India
2   Yashoda Hospitals, Hyderabad, India
› Author Affiliations

Abstract

Toxoplasmosis is a rare but important infection in pregnant women which can potentially cause serious fetal adverse effects. Methods of screening, diagnosing and treating toxoplasmosis in pregnancy have been evaluated for over four decades now but still, there is a lack of robust evidence in these areas to guide care plans. Yet with the advent of newer techniques in imaging and laboratory diagnosis, reasonable protocols can be formulated to optimally mange cases with toxoplasmosis in pregnancy. It is becoming increasingly evident that antenatal treatment definitely helps in reducing fetal and hence neonatal morbidity from this infection. Timely identification and adequate therapy to prevent vertical transmission or even treat infected fetuses seem to be a practical approach. Most importantly, health education and public awareness will help reduce the infection rates in pregnant women.



Publication History

Received: 21 July 2019

Accepted: 23 October 2019

Article published online:
05 May 2023

© 2019. Society of Fetal Medicine. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India